| Phase 4 |
| NCT05185505 |
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular… |
Hepatocellular Carcinoma |
Recruiting |
| NCT06384651 |
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty |
Infections |
Recruiting |
| NCT06511232 |
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction |
Anterior Cruciate Ligament Tear |
Recruiting |
| NCT04665310 |
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant |
Kidney Disease, End-Stage |
Active, Not Recruiting |
| NCT05831774 |
IO Vancomycin in TSA |
Shoulder Injuries |
Active, Not Recruiting |
| Phase 3 |
| NCT07290491 |
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With… |
Cancer |
Recruiting |
| Phase 2/3 |
| NCT06748144 |
IO Vancomycin Spine |
Lumbar Fusion Surgery |
Not Yet Recruiting |
| Phase 2 |
| NCT04494724 |
Clazakizumab vs. Placebo - COVID-19 Infection |
COVID-19 Infection |
Recruiting |
| NCT06887218 |
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With… |
Metastatic Colorectal Cancer (CRC) |
Recruiting |
| NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative… |
ER-Positive Breast Cancer |
Recruiting |
| NCT07050771 |
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major… |
Hepatopancreaticobiliary (HPB) Malignancy |
Recruiting |
| NCT07042685 |
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients… |
Metastatic Colorectal Cancer (CRC) |
Recruiting |
| NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast… |
HER2-negative Breast Cancer |
Recruiting |
| NCT05511246 |
Venous Ethanol for Ventricular Tachycardia |
Ventricular Tachycardia |
Recruiting |
| NCT07383649 |
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial… |
Brain Cancer Metastatic |
Recruiting |
| NCT04055623 |
T-regulatory Cells in ALS |
ALS (Amyotrophic Lateral Sclerosis) |
Active, Not Recruiting |
| NCT05171335 |
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large… |
Hepatocellular Carcinoma |
Enrolling by Invitation |
| NCT03478215 |
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation |
Renal Transplantation |
Active, Not Recruiting |
| NCT05285878 |
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following… |
Interstitial Fibrosis |
Enrolling by Invitation |
| NCT05241340 |
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible… |
Urothelial Carcinoma Bladder |
Active, Not Recruiting |
| NCT06751602 |
Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney… |
Rejection Chronic Renal |
Enrolling by Invitation |
| NCT07060001 |
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia… |
Acute Myeloid Leukemia (AML) |
Not Yet Recruiting |
| NCT03820141 |
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer |
Breast Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate… |
Prostatic Neoplasms |
Recruiting |
| NCT06640491 |
Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA) |
Total Knee Arthroplasty |
Recruiting |